These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4704170)

  • 1. Glycogen accumulation in neurogenic bladder muscle. A reappraisal.
    Wein AJ; Gregory JG; Sansone TC; Rohner TJ; Schoenberg HW
    Invest Urol; 1973 May; 10(6):442-3. PubMed ID: 4704170
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical comparison of normal and neurogenic animal bladder muscle. II. Glycogen changes in dog bladder muscle after spinal cord transection: a quantitative study.
    Rohner TJ; Komins J; Braslow NH; Schoenberg HW
    Invest Urol; 1968 Jul; 6(1):16-20. PubMed ID: 5243054
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical comparison of normal and neurogenic animal bladder muscle. I. Changes in glycogen content of dog bladder muscle after spinal cord transection.
    Rohner TJ; Schoenberg HW
    Invest Urol; 1968 Jul; 6(1):9-15. PubMed ID: 5243055
    [No Abstract]   [Full Text] [Related]  

  • 4. Reinnervation of the neurogenic bladder with somatic motor nerves.
    Rao CR; Bruce AW; Lywood DW; Robertson DM
    Invest Urol; 1971 Jul; 9(1):59-63. PubMed ID: 5563427
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular analysis of collagens in bladder fibrosis.
    Deveaud CM; Macarak EJ; Kucich U; Ewalt DH; Abrams WR; Howard PS
    J Urol; 1998 Oct; 160(4):1518-27. PubMed ID: 9751406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress urinary incontinence in women. III. Different tissue biochemistry in patients with concomitant detrusor instability. Preliminary report.
    Jóźwik M; Jóźwik M; Lotocki W
    Int Urol Nephrol; 1998; 30(3):279-82. PubMed ID: 9696333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in pituitary adenylate cyclase activating polypeptide expression in urinary bladder pathways after spinal cord injury.
    Zvarova K; Dunleavy JD; Vizzard MA
    Exp Neurol; 2005 Mar; 192(1):46-59. PubMed ID: 15698618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of bladder smooth muscle orientation in normal and spinal cord injured rats.
    Nagatomi J; Toosi KK; Grashow JS; Chancellor MB; Sacks MS
    Ann Biomed Eng; 2005 Aug; 33(8):1078-89. PubMed ID: 16133916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental studies on the neurogenic bladder. XVI. Pathological observation on the extension of inflammatory process in the urinary tract].
    Saito K
    Nihon Hinyokika Gakkai Zasshi; 1971 Jul; 62(7):527-40. PubMed ID: 5165093
    [No Abstract]   [Full Text] [Related]  

  • 10. [Morphometric study of low compliant bladder].
    Ohnishi N; Kishima Y; Hashimoto K; Kiwamoto H; Esa A; Sugiyama T; Park YC; Kurita T
    Hinyokika Kiyo; 1994 Aug; 40(8):657-61. PubMed ID: 7942361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sonographic demonstration of an unusual bladder wall enlargement in a child with non-Hodgkin lymphoma].
    Ponhold W; Schilling R; Vergesslich K; Jürgenssen OA
    Padiatr Padol; 1985; 20(4):397-402. PubMed ID: 3909066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
    Howard PS; Renfrow D; Schechter NM; Kucich U
    Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity.
    Giannantoni A; Di Stasi SM; Nardicchi V; Zucchi A; Macchioni L; Bini V; Goracci G; Porena M
    J Urol; 2006 Jun; 175(6):2341-4. PubMed ID: 16697870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of smooth muscle myosin isoforms in urinary bladder smooth muscle during hypertrophy and regression.
    Wang ZE; Gopalakurup SK; Levin RM; Chacko S
    Lab Invest; 1995 Aug; 73(2):244-51. PubMed ID: 7637325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenotypic changes in human bladder smooth muscle cell].
    Matsumoto S; Hanai T; Kurita T; Akiyama T
    Hinyokika Kiyo; 2003 Dec; 49(12):715-9. PubMed ID: 14978953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal polypeptide in the hyper-reflexic neuropathic bladder.
    Kinder RB; Restorick JM; Mundy AR
    Br J Urol; 1985 Jun; 57(3):289-91. PubMed ID: 4005496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of neurogenic bladder dysfunction. I. Methods of prospective ultrastructural study and overview of the findings.
    Elbadawi A; Resnick NM; Dörsam J; Yalla SV; Haferkamp A
    J Urol; 2003 Feb; 169(2):540-6. PubMed ID: 12544304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of connexin 43 in the overactive neurogenic detrusor.
    Haferkamp A; Mundhenk J; Bastian PJ; Reitz A; Dörsam J; Pannek J; Schumacher S; Schurch B; Büttner R; Müller SC
    Eur Urol; 2004 Dec; 46(6):799-805. PubMed ID: 15548450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen distribution in dog skeletal muscle.
    Chapler CK; Moore WG
    J Appl Physiol; 1972 Apr; 32(4):542-5. PubMed ID: 5026507
    [No Abstract]   [Full Text] [Related]  

  • 20. [Work capacity and glycogen content of skeletal muscle].
    Hirche H; Biebrach M; Grün D; Müller-Ruchholtz ER; Waller W
    Pflugers Arch; 1969; 312(1):R95-6. PubMed ID: 5390316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.